Skip to main content

Table 2 Basic characteristics of trials included in the present study

From: Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis

Reference

Author

Year

Metastasis

Adjuvant chemotherapy

With palliative gastrectomy

Without palliative gastrectomy

1-year survival

3-year survival

5-year survival

Follow-up(month)

HR (95%CI)

Patients number

Median survival time (month)

Ptaients number

Median survival time (month)

with PG

without PG

with PG

without PG

with PG

without PG

1

Kikuchi S [26]

1998

M1

-

63

12.2

59

5.5

NA

NA

NA

NA

NA

NA

40

0.55 (0.35,0.85)

2

Saidi RF [27]

2006

M0 + M1

±

24

13.2

81

5.5

NA

NA

NA

NA

5%

0

60

0.46 (0.03,7.2)

3

Nazli O [28]

2007

M0

-

21

8

39

3

NA

NA

NA

NA

NA

NA

36

NA

4

Lin SZ [29]

2008

M0 + M1

±

183

NA

206

NA

61.3%

1.3%

8.9%

0

6.2%

0

60

0.61 (0.45,0.82)

5

Lupascu C [30]

2010

M0 + M1

±

30

17.8

45

6.4

NA

NA

NA

NA

NA

NA

30

0.78 (0.06,9.64)

6

Zhang JZ [31]

2011

M0 + M1

-

184

16.4

152

5.5

51.4%

0

NA

NA

NA

NA

60

0.64 (0.49,0.84)

7

Sougioultzis S [32]

2011

M0 + M1

+

218

13.25

93

4

NA

NA

8.1%

3.5%

NA

NA

75

0.08 (0.06,0.13)

8

Kim KH [33]

2011

M1

+

47

15.5

185

9

NA

NA

NA

NA

NA

NA

60

0.65 (0.45,0.94)

9

Chang YR [34]

2011

M1

±

108

12.7

57

11.2

NA

NA

NA

NA

NA

NA

60

0.59 (0.42,0.89)

10

Kokkola A [35]

2012

M1

±

23

10.8

32

5.7

NA

NA

NA

NA

NA

NA

60

0.99 (0.5,1.94)

11

Chen S [36]

2012

M0 + M1

±

392

NA

470

NA

NA

NA

NA

NA

NA

NA

48

0.71 (0.58,0.87)

12

Tokunaga M [37]

2012

M1

±

82

13.1

66

12

NA

NA

NA

NA

NA

NA

60

1.03 (0.65,1.65)

13

Miki Y [38]

2012

M1

±

38

25.6

12

8.7

64.4%

36.7%

36.1%

12.2%

29.4%

0

83

0.27 (0.12,0.59)

14

Dittmar Y [39]

2012

M0 + M1

±

48

15

45

6

NA

NA

NA

NA

NA

NA

60

0.56 (0.32,0.99)

Total publications: 14

   

1461

14.96*

1542

7.07*

        
  1. +: all patients received chemotherapy. -: chemotherapy was not mentioned. ±: a part of patients received chemotherapy.
  2. *: weighted average of median survival time of articles.